ADSSL1 myopathy is the most common nemaline myopathy in Japan with variable clinical features

Objective To elucidate the prevalence of Japanese ADSSL1 myopathy and determine the clinicopathologic features of the disease. Methods We searched for ADSSL1 variants in myopathic patients from January 1978 to March 2019 in our repository and assessed the clinicopathologic features of patients with variants. Results We identified 63 patients from 59 families with biallelic variants of ADSSL1. Among the 7 distinct variants identified, c.781G>A and c.919delA accounted for 53.2% and 40.5% of alleles, respectively, suggesting the presence of common founders, while the other 5 were novel. Most of the identified patients displayed more variable muscle symptoms, including symptoms in the proximal and/or distal leg muscles, tongue, masseter, diaphragm, and paraspinal muscles, in adolescence than previously reported patients. Dysphagia with masticatory dysfunction developed in 26 out of 63 patients; hypertrophic cardiomyopathy developed in 12 out of 48 patients; and restrictive ventilatory insufficiency developed in 26 out of 34 patients in later stages. Radiologically, fat infiltration into the periphery of vastus lateralis, gastrocnemius, and soleus muscles was observed in all patients. Pathologically, nemaline bodies in addition to increased lipid droplets and myofibrillar disorganization were commonly observed in all patients, suggesting that the disease may be classified as nemaline myopathy. This finding revealed that ADSSL1 myopathy is the most frequent among all genetically diagnosable nemaline myopathies in our center. Conclusions ADSSL1 myopathy is characterized by more variable manifestations than previously reported. It is the most common among all genetically diagnosable nemaline myopathies in our center, although mildly increased lipid droplets are also constantly observed features.

[1]  J. Lee,et al.  Distal myopathy with ADSSL1 mutations in Korean patients , 2017, Neuromuscular Disorders.

[2]  S. Han,et al.  Electron Microscopy Pathology of ADSSL1 Myopathy , 2016, Journal of Clinical Neurology.

[3]  I. Nishino,et al.  Targeted massively parallel sequencing and histological assessment of skeletal muscles for the molecular diagnosis of inherited muscle disorders , 2016, Journal of Medical Genetics.

[4]  T. Kishimoto,et al.  Early onset of cardiomyopathy and intellectual disability in a girl with Danon disease associated with a de novo novel mutation of the LAMP2 gene , 2016, Neuropathology : official journal of the Japanese Society of Neuropathology.

[5]  I. Nonaka,et al.  Hepatitis C virus infection in inclusion body myositis , 2016, Neurology.

[6]  최영철,et al.  ADSSL1 mutation relevant to autosomal recessive adolescent onset distal myopathy , 2016 .

[7]  I. Nonaka,et al.  Dominant mutations in ORAI1 cause tubular aggregate myopathy with hypocalcemia via constitutive activation of store-operated Ca²⁺ channels. , 2015, Human molecular genetics.

[8]  S. Sandaradura,et al.  Recent advances in nemaline myopathy , 2013, Current opinion in neurology.

[9]  Volker Straub,et al.  TREAT-NMD workshop: Pattern recognition in genetic muscle diseases using muscle MRI 25–26 February 2011, Rome, Italy , 2012, Neuromuscular Disorders.

[10]  P. Laforêt,et al.  Disorders of muscle lipid metabolism: Diagnostic and therapeutic challenges , 2010, Neuromuscular Disorders.

[11]  I. Nishino,et al.  State of the art in muscle lipid diseases , 2010, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[12]  J. Allsop,et al.  Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy , 2005, Neuromuscular Disorders.

[13]  Nan Li,et al.  Molecular cloning and characterization of a novel muscle adenylosuccinate synthetase, AdSSL1, from human bone marrow stromal cells , 2005, Molecular and Cellular Biochemistry.

[14]  L. Machesky,et al.  Congenital myopathies: diseases of the actin cytoskeleton , 2004, The Journal of pathology.

[15]  U. de Girolami,et al.  Clinical course correlates poorly with muscle pathology in nemaline myopathy , 2003, Neurology.

[16]  H. Fromm,et al.  IMP, GTP, and 6-Phosphoryl-IMP Complexes of Recombinant Mouse Muscle Adenylosuccinate Synthetase* , 2002, The Journal of Biological Chemistry.

[17]  Y. Xia,et al.  The adenylosuccinate synthetase‐1 gene is activated in the hypertrophied heart , 2002, Journal of cellular and molecular medicine.

[18]  A. Beggs,et al.  Clinical and genetic heterogeneity in nemaline myopathy--a disease of skeletal muscle thin filaments. , 2001, Trends in molecular medicine.

[19]  J. Brucher,et al.  Enzymes of the purine nucleotide cycle in muscle of patients with exercise intolerance , 1998, Muscle & nerve.

[20]  O. Guicherit,et al.  Molecular cloning and expression of a mouse muscle cDNA encoding adenylosuccinate synthetase. , 1991, The Journal of biological chemistry.